Voriconazol-Mepha i.v. 200 mg
Voriconazol-Mepha i.v. 200 mg is a medicine authorised by Swissmedic under authorisation number 65315. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 12 October 2015 and the authorisation is valid without a time limit. ATC code J02AC03 places the medicine in the group Antimycotics for systemic use.
| Authorisation number | 65315 |
|---|---|
| Name | Voriconazol-Mepha i.v. 200 mg |
| Full name | Voriconazol-Mepha i.v. 200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | J02AC03 |
| First authorisation | 12 October 2015 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Voriconazol-Mepha i.v. 200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 12 October 2015 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 2 | 1 | Durchstechflasche(n) | J02AC03 | 08.06.0. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Voriconazol-Mepha i.v. 200 mg authorised in Switzerland?
Yes. Voriconazol-Mepha i.v. 200 mg is authorised by Swissmedic under authorisation number 65315, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Voriconazol-Mepha i.v. 200 mg have?
Voriconazol-Mepha i.v. 200 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Voriconazol-Mepha i.v. 200 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.